Quest Diagnostics Incorporated (FRA:QDI)

Market Cap	18.16B
Revenue (ttm)	8.96B
Net Income (ttm)	804.67M
Shares Out	n/a
EPS (ttm)	7.11
PE Ratio	22.57
Forward PE	18.60
Dividend	2.82 (1.76%)
Ex-Dividend Date	Jul 7, 2025

Volume	n/a
Average Volume	43
Open	160.85
Previous Close	158.10
Day's Range	160.85 - 160.85
52-Week Range	133.50 - 168.15
Beta	n/a
RSI	64.42
Earnings Date	Oct 21, 2025

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans,...

• Industry: Medical Laboratories
• Founded: 1967
• Employees: 56,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: QDI

Financial Performance

In 2024, Quest Diagnostics's revenue was $9.87 billion, an increase of 6.70% compared to the previous year's $9.25 billion. Earnings were $866.00 million, an increase of 1.88%.

Financial numbers in USD